Monitoring and Assessment Framework for the
EIP on Active and Healthy Ageing (MAFEIP)
|back to the eHealth main page|
The MAFEIP project started in September 2012 as a cooperation between JRC-IPTS, DG CONNECT and DG SANCO in the context of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA).
The EIP on AHA was the first Innovation Partnership to be launched by the European Commission in 2011 as part of the Innovation Union, one of the seven flagship initiatives of the Europe 2020 strategy for growths and jobs. The Innovation Partnerships have been conceived to address weaknesses in the European research and innovation system which prevent innovation from making it to the market stage. In the context of an ageing European population, active and healthy ageing has been identified by the European Commission as both a major societal challenge common to all European countries and an opportunity for Europe to take the lead in providing innovative solutions in this field which the pilot European Innovation Partnership on Active and Healthy Ageing will seek to address. More specifically, the EIP on AHA aims to add, by 2020, two healthy life years (HLY) to the average healthy life span of European citizens. In achieving this, the Partnership seeks to pursue a triple win for Europe:
Besides defining priority areas of work and Specific Actions, the Strategic Implementation Plan for the EIP on AHA foresees the creation of Action Groups whose aim is to "jointly carry out the selected actions, address specific barriers, seeking synergies and breaking silos".
The EIP Steering Group selected the following six Specific Actions from the Strategic Implementation Plan as priority areas to be considered in establishing a Monitoring Framework:
The role of the JRC-IPTS is to support with the definition of a common monitoring framework which should facilitate and harmonise the monitoring of the process and outcome indicators of the individual actions, six specific Actions Groups and their influence on the triple win and the overall objective of two healthy life years.
More specifically the MAFEIP study aims to: